Navigation Links
Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting
Date:12/10/2007

483-2839

Mary Anne Rhyne 919-483-2839

US Analyst/Investor inquiries:

Frank Murdolo 215-751-7002

Tom Curry 215-751-5419

REFERENCES

(1) Bussel, JB., Cheng, G., et al. Long-term safety and efficacy of oral eltrombopag for the treatment of subjects with idiopathic thrombocytopenic purpura (ITP): preliminary data from the EXTEND study. Blood. 2007; 110 (11). Published online, Nov 2007.

(2) McMillan, R., Bussel, JB., et al. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am Hematol. Published online, 23 Aug 2007.

(3) Cines, DB., McMillan, R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med. 2005;56: 425-442.

(4) Idiopathic Thrombocytopenic Purpura (ITP) factsheet. Great Ormond Street Hospital for Children NHS Trust. August 2004.

(5) About ITP. Platelet Disorder Support Association (PDSA). Available at http://www.pdsa.org/itp-information/index.html . Accessed 23 November 2007.

(6) Jenkins J, Williams D, Deng Y, et al. Phase I clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist. Blood. 2007: 109:4739-4741.

(7) Erickson-Miller, C., Delorme, E., et al Biological Activity and Selectivity for TPO Receptor of the Orally Bioavailable, Small Molecule TPO receptor Agonist, SB-497115. Blood. 2004; 104:796a.

(8) Study TRA105325 protocol.

(9) Bussel, J., Cheng, G., et al. Analysis of Bleeding in Patients with Immune Thrombocytopenic Purpura (ITP): A Randomized, Double-Blind, Placebo-Controlled Trial of Eltrombopag, an Oral Platelet Growth Factor. Blood. 2006; 108: 475.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
2. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
3. Sexual Function Affected by Stem Cell Transplant According to Long-Term Study
4. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
5. Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501
6. New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG
7. Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)
8. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
9. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
10. Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
11. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating potential ... ("Advaxis" or the "Company") (NASDAQ: ADXS ), ... to shareholders. On January 21, 2015, an ... Advaxis had misrepresented the clinical data for its ADXS-HPV ...
(Date:1/23/2015)... Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned itself ... share and grab a foothold in the hydroponic, hemp and ... and a presence in the sector, and recently partnering with ... of hemp and medical marijuana, iMD is committing to bring ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... Simulated Environment Concepts (SMEV.PK), the manufacturer and developer of ... that the Company has entered into what they believe may ... expects that much of the difficult items in prepping the ... much more knowledgeable today about the auditing process than they ...
... Md., July 1, 2011 The U.S. Food ... inhalation powder) for the long term, once-daily maintenance ... chronic obstructive pulmonary disease (COPD) including chronic bronchitis ... COPD is a serious lung ...
Cached Medicine Technology:Simulated Environment Concepts Nears Audit Completion 2Simulated Environment Concepts Nears Audit Completion 3FDA Approves Arcapta Neohaler to Treat Chronic Obstructive Pulmonary Disease 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 Gabe’s Chemo Duck Program ... App, the first app ever created for kids with cancer. The ... phones and devices, is filled with enjoyable games to help children ... treatments. The free app helps to keep kids entertained, educated and ...
(Date:1/22/2015)... a famous wedding dress company offering many trendy designs. Today, ... Twitter, and Pinterest. The fans will have an opportunity to ... week. , Moreover, the company has extended its 2015 New ... for more information. , Angelweddingdress is a famous ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David ... Show to bestow a Juvent Sports Achievement award upon ... McKitrick. The award commemorated and congratulated McKitrick for her ... won her first amateur tournament in 1979 and most ...
(Date:1/22/2015)... 22, 2015 For over 20 years, Dr. David ... and Vista area has treated just about every type of ... circumstances. And for those same twenty-plus years, the team at ... those injuries with the best possible doctor. With the ...
(Date:1/22/2015)... January 22, 2015 Yesterday, Senator ... (D-Concord) and Kristin Olsen (R-Modesto) were honored by ... in advancing biotechnology, biomedical science, medical device and ... each received the “2014 Life Sciences Champion” award ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
... Jan. 11 Welcome to Consumer,Reports Health ... Reports,and ConsumerReports.org cover issues pertaining to the ... (including natural medicines),mental health, diet and nutrition, ... fitness products, rates the effectiveness and affordability ...
... Fla., Jan. 11 Breckenridge,Pharmaceutical, Inc. announced ... Novartis concerning Trileptal(R) and that the U.S. ... Drug,Application for oxcarbazepine 150mg, 300mg and 600 ... Breckenridge enjoys a shared 180-day exclusivity ...
... caused by type 2 diabetes will more than double ... major causes falls, according to new research by The,University ... published in the January 7 edition of the Medical ... and injury in Australia from 1993 to 2023,measuring the ...
... study finds cholesterol-lowering drugs reduce risk of major vascular events ... with diabetes should be considered for treatment with cholesterol-lowering statins. ... in the Jan. 12 issue of The Lancet . ... the risk of major vascular events in a wide range ...
... Fla., Jan. 11 Life Brokerage Partners,announces ... National,Life Group and Nationwide. With these new ... to products at some of the most,exclusive ... as a,national insurance brokerage agency., New ...
... Jan. 11 /Xinhua-PRNewswire/ -- Sundia MediTech,(Shanghai) Company recently announced ... Dr. Joseph Zhu and Dr. Shu Gao. Dr. Zhu ... Dr. Gao as the Vice,President in charge of Chemical ... Zhu got his college,education in chemistry in Nanjing University ...
Cached Medicine News:Health News:Consumer Reports Health News 2Health News:Consumer Reports Health News 3Health News:Consumer Reports Health News 4Health News:UQ research predicts type 2 diabetes explosion 2Health News:Statin Therapy Helps Diabetic Patients 2Health News:Life Brokerage Partners Adds New Insurance Carriers 2Health News:CRO Company Sundia Welcomes New Members to Its Executive Team 2
... The MEL 80 is a top ... make the correction of vision defects even ... parameters of this ultramodern work platform are ... results and the rapid recovery of vision. ...
An aid for advancing a pacemaker lead through the subcutaneous tissue of the chest wall to the pacemaker pocket....
BonePlast is a fast resorbing, osteoconductive bone void filler. By delivering a high dose of calcium to the operative site, BonePlast helps build new bone during the healing process. Packaged in a c...
LifeStent FlexStar delivery systems offer clinicians multiple methods for stent deployment to accommodate individual preference....
Medicine Products: